$10.51
-0.34 (-3.13%)
Open$10.50
Previous Close$10.85
Day High$10.51
Day Low$10.50
52W High$46.66
52W Low$32.83
Volume—
Avg Volume474.3K
Market Cap88.15M
P/E Ratio48.80
EPS$0.81
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 13.14M | 13.93M | 11.00M |
| Net Income | -2,417,675 | -2,785,079 | -2,350,186 |
| Profit Margin | -18.4% | -20.0% | -21.4% |
| EBITDA | -3,490,436 | -4,206,535 | -3,083,781 |
| Free Cash Flow | -1,263,655 | -1,934,401 | -1,577,892 |
| Rev Growth | -4.0% | +11.1% | -5.6% |
| Debt/Equity | 0.43 | 0.38 | 0.34 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |